Literature DB >> 25711154

High-resolution MRI analysis of breast cancer xenograft on the chick chorioallantoic membrane.

Zhi Zuo1, Tatiana Syrovets, Felicitas Genze, Alireza Abaei, Genshan Ma, Thomas Simmet, Volker Rasche.   

Abstract

The chick chorioallantoic membrane (CAM) model has been successfully used to study angiogenesis, cancer progression and its pharmacological treatment, tumor pharmacokinetics, and properties of novel nanomaterials. MRI is an attractive technique for non-invasive and longitudinal monitoring of physiological processes and tumor growth. This study proposes an age-adapted cooling regime for immobilization of the chick embryo, enabling high-resolution MRI of the embryo and the CAM tumor xenograft. 64 chick embryos were enrolled in this study. The novel immobilization and imaging protocol was optimized in 29 embryos. From d7 to d18 immobilization of the embryo up to 90 min was achieved by cooling at 4 °C pre-imaging, with cooling times adapted to age. Its application to tumor growth monitoring was evaluated in 15 embryos after xenotransplantation of human MDA-MB-231 breast cancer cells on CAM. Tumor volumes were monitored from d4 to d9 after grafting (d11 to d16 after incubation) applying a T2 -weighted multislice RARE sequence. At d9 after grafting, the tumors were collected and compared with the MRI-derived data by histology and weight measurements. Additional imaging methods comprising DWI, T2 mapping, and the bio-distribution of contrast agents were tested at d9 after grafting in 20 further embryos. With the adaptive cooling regime, motion artifacts could be completely avoided for up to 90 min scan time, enabling high-resolution in ovo imaging. Excellent anatomical details could be obtained in the embryo and tumors. Tumor volumes could be quantified over time. The results prove the feasibility of high-resolution MRI for longitudinal tumor and organ growth monitoring. The suggested method is promising for future applications such as testing tailored and/or targeted treatment strategies, longitudinal monitoring of tumor development, analysis of therapeutic efficacies of drugs, or assessment of tumor pharmacokinetics. The method provides an alternative to animal experimentation.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  CAM; breast cancer xenograft; chick chorioallantoic membrane; high resolution; in ovo; magnetic resonance imaging; tumor

Mesh:

Substances:

Year:  2015        PMID: 25711154     DOI: 10.1002/nbm.3270

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  11 in total

Review 1.  Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies.

Authors:  Pei-Yu Chu; Angele Pei-Fern Koh; Jane Antony; Ruby Yun-Ju Huang
Journal:  Cells Tissues Organs       Date:  2021-03-29       Impact factor: 2.208

2.  Probing Vasoreactivity and Hypoxic Phenotype in Different Tumor Grafts Grown on the Chorioallantoic Membrane of the Chicken Embryo In Ovo Using MRI.

Authors:  Johanna Buschmann; Dorothea M Heuberger; Fatma Kivrak Pfiffner; Petra Wolint; Jae-Hwi Jang; Wolfgang Jungraithmayr; Pietro Giovanoli; Maurizio Calcagni; Conny F Waschkies
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

Review 3.  The 3D in vivo chorioallantoic membrane model and its role in breast cancer research.

Authors:  Cynthia Kohl; Thiha Aung; Silke Haerteis; Atanas Ignatov; Olaf Ortmann; Thomas Papathemelis
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-05       Impact factor: 4.322

4.  The CAM Assay as an Alternative In Vivo Model for Drug Testing.

Authors:  Regine Schneider-Stock; Domenico Ribatti
Journal:  Handb Exp Pharmacol       Date:  2021

5.  The CAM cancer xenograft as a model for initial evaluation of MR labelled compounds.

Authors:  Zhi Zuo; Tatiana Syrovets; Yuzhou Wu; Susanne Hafner; Ina Vernikouskaya; Weina Liu; Genshan Ma; Tanja Weil; Thomas Simmet; Volker Rasche
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

6.  Magnetic Resonance Imaging for Characterization of a Chick Embryo Model of Cancer Cell Metastases.

Authors:  Anne Herrmann; Arthur Taylor; Patricia Murray; Harish Poptani; Violaine Sée
Journal:  Mol Imaging       Date:  2018 Jan-Dec       Impact factor: 4.488

7.  Multi-Modal PET and MR Imaging in the Hen's Egg Test-Chorioallantoic Membrane (HET-CAM) Model for Initial in Vivo Testing of Target-Specific Radioligands.

Authors:  Gordon Winter; Andrea B F Koch; Jessica Löffler; Mika Lindén; Christoph Solbach; Alireza Abaei; Hao Li; Gerhard Glatting; Ambros J Beer; Volker Rasche
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

8.  Blocking Studies to Evaluate Receptor-Specific Radioligand Binding in the CAM Model by PET and MR Imaging.

Authors:  Jessica Löffler; Hendrik Herrmann; Ellen Scheidhauer; Mareike Wirth; Anne Wasserloos; Christoph Solbach; Gerhard Glatting; Ambros J Beer; Volker Rasche; Gordon Winter
Journal:  Cancers (Basel)       Date:  2022-08-10       Impact factor: 6.575

9.  Tumor grafts grown on the chicken chorioallantoic membrane are distinctively characterized by MRI under functional gas challenge.

Authors:  Conny F Waschkies; Fatma Kivrak Pfiffner; Dorothea M Heuberger; Marcel A Schneider; Yinghua Tian; Petra Wolint; Maurizio Calcagni; Pietro Giovanoli; Johanna Buschmann
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

10.  Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer.

Authors:  Gustav Steinemann; Alexandra Dittmer; Jacob Schmidt; David Josuttis; Michael Fähling; Bernhard Biersack; Nicola Beindorff; Eva Jolante Koziolek; Rainer Schobert; Winfried Brenner; Thomas Müller; Bianca Nitzsche; Michael Höpfner
Journal:  Mol Oncol       Date:  2019-10-22       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.